PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Guidelines : Heart failure

Guidelines : Heart failure

Additional Documents

Type
Document
Review Date
Guidelines (Local)
Heart Failure Treatment Pathway - Surrey Heartlands Feb 2024
03 February 2027
Webpage
NICE TA267 Ivabradine for Chronic Heart Failure
Webpage
NICE TA388 - Sacubitril Valsartan in Chronic Heart Failure
Webpage
NICE TA679 - Dapagliflozin for chronic heart failure with reduced ejection fraction - Feb 2021
Webpage
NICE TA773 - Empagliflozin for treating chronic heart failure with reduced ejection fraction (March 2022)
Webpage
NICE TA902 Dapagliflozin for Chronic Heart Failure with Preserved or Mildly Reduced Ejection Fraction
Webpage
NICE TA929 - Empagliflozin for treating chronic heart failure with preserved or moderately reduced ejection fraction - Nov 23

Other Drugs

Committee Recommendations

Date
Committee Name
Narrative
07 February 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approved an updated treatment pathway for chronic heart failure.

NICE guidance for Chronic Heart Failure in adults can also be found here: Chronic Heart Failure in adults

This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More